Search

Your search keyword '"Ingels, Alexandre"' showing total 342 results

Search Constraints

Start Over You searched for: Author "Ingels, Alexandre" Remove constraint Author: "Ingels, Alexandre"
342 results on '"Ingels, Alexandre"'

Search Results

4. Late complications and 5 years outcomes of robotic partial nephrectomy in France: prospective assessment in the French Kidney Cancer Research Network (UroCCR 10)

5. 2023 WSES guidelines for the prevention, detection, and management of iatrogenic urinary tract injuries (IUTIs) during emergency digestive surgery

6. Clinical trial protocol for P-NeLoP: a randomized controlled trial comparing the feasibility and outcomes of robot-assisted partial nephrectomy with low insufflation pressure using AirSeal versus standard insufflation pressure (UroCCR no. 85 study)

8. Effect of Serelys Homme on the Incidence and Severity of Vasomotor Symptoms and Quality-of-Life Impairments in Patients Receiving Hormone Therapy and Radiation for Localized Prostate Cancer: Results of the ESCULAPE Phase 2 Prospective Study

9. Resection Techniques During Robotic Partial Nephrectomy: A Systematic Review

10. Application of Machine Learning Models to Predict Recurrence After Surgical Resection of Nonmetastatic Renal Cell Carcinoma

11. Robotic Partial Nephrectomy

12. Open Radical Nephrectomy

13. Robotic Radical Nephrectomy

14. Decision-Making for Patients with Localized Renal Masses

15. Active Surveillance and Watchful Waiting in Renal Cancer

16. Management of Localized Renal Masses: The European Association of Urology (EAU), American Urological Association (AUA) and American Society of Clinical Oncology (ASCO) Guidelines’ Perspective

17. Ablative Therapies in Renal Cancer

19. Mapping European Association of Urology Guideline Practice Across Europe: An Audit of Androgen Deprivation Therapy Use Before Prostate Cancer Surgery in 6598 Cases in 187 Hospitals Across 31 European Countries

21. Urethrectomy at the time of radical cystectomy for non-metastatic urothelial carcinoma of the bladder: a collaborative multicenter study

23. PD18-11 DELAYED PARTIAL NEPHRECTOMY FOLLOWING COMPLETE RESPONSE TO IMMUNOTHERAPY: FEASIBILITY AND RESULTS (UROCCR N°157)

24. Oncological Outcomes of Delayed Nephrectomy After Optimal Response to Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma

26. Potential benefit of lymph node dissection during radical nephrectomy for kidney cancer: A review and critical analysis of current literature

27. Ablative Therapies in Renal Cancer

28. Robotic Radical Nephrectomy

29. Open Partial Nephrectomy: Current Status in the Minimally-Invasive Surgery Era

30. Decision-Making for Patients with Localized Renal Masses

31. Management of Localized Renal Masses: The European Association of Urology (EAU), American Urological Association (AUA) and American Society of Clinical Oncology (ASCO) Guidelines’ Perspective

32. Robotic Partial Nephrectomy

33. Active Surveillance and Watchful Waiting in Renal Cancer

34. Open Radical Nephrectomy

38. Glomerular Filtration Rate Measured Based on Iomeprol Clearance Assessed at CT Urography in Living Kidney Donor Candidates

39. BR55 Ultrasound Molecular Imaging of Clear Cell Renal Cell Carcinoma Reflects Tumor Vascular Expression of VEGFR-2 in a Patient-Derived Xenograft Model

40. Postoperative outcomes of elderly patients undergoing partial nephrectomy

42. Retroperitoneal vs. transperitoneal robotic partial nephrectomy: a multicenter propensity-score matching analysis (PADORA Study - UroCCR n° 68)

43. Artificial Intelligence in Renal Cell Carcinoma Histopathology: Current Applications and Future Perspectives

44. The clinical role of the TME in solid cancer

46. Surgical and oncological management of renal medullary carcinoma in a young patient: a case report

47. Mapping European Association of Urology Guideline Practice Across Europe: An Audit of Androgen Deprivation Therapy Use Before Prostate Cancer Surgery in 6598 Cases in 187 Hospitals Across 31 European Countries

48. MP64-07 DEVELOPMENT OF AN INDIVIDUAL POSTOPERATIVE PREDICTION MODEL FOR KIDNEY CANCER RECURRENCE USING MACHINE LEARNING (UroCCR STUDY 120)

49. Impact of Serelys® Homme on the incidence and severity of vasomotor symptoms and quality of life impairments in patients receiving hormone therapy and radiotherapy for localized prostate cancer. Results of the ESCULAPE phase II prospective study.

Catalog

Books, media, physical & digital resources